Home » Resource Library

All resources from

Mpox Resource Center

Learn about Mpox and Safer Sex

July 16, 2024

These downloadable fact sheets from the CDC answer common questions about safer sex, social gatherings, and mpox.

Read More

Mpox Resources from Greater Than

July 12, 2024

Demetre Daskalakis, MD, MPH, Acting Director of the National Center for Immunization and Respiratory Diseases at the CDC, provides the latest on mpox in this FAQ series from KFF and CDC.

Read More

U.S. Mpox Wastewater Data

July 10, 2024

Communities can monitor the presence of mpox virus in wastewater samples. Data from samples can provide an early warning of mpox activity and spread in communities. This dashboard from the CDC displays the latest sample data.

Read More

Tecovirimat (TPOXX) for Treatment of Mpox

July 9, 2024

To help meet domestic and international mpox response goals, CDC is urging clinicians to let patients with mpox know that oral tecovirimat is available through STOMP and encourage them to enroll. Providers should inform patients about STOMP so they can consider enrolling in the study.

Read More

Guidance for Tecovirimat (TPOXX)

Tecovirimat (TPOXX) and Guidance for Tecovirimat Use pages are now live.

Read More

U.S. Mpox Case Trends Reported to CDC

July 1, 2024

This dashboard displays trends of mpox cases reported to CDC during the 2022 outbreak by date. As of May 1, 2024, U.S. mpox case trends data will be updated the first week of every month.

Read More

Mpox Information for Health Departments

June 25, 2024

This resource page from the CDC provides examples and best practices for slowing the spread of mpox.

Read More

Case Definitions for Use in the Mpox Response

June 10, 2024

These case definitions from the CDC enable public health officials to classify and count mpox cases consistently across reporting jurisdictions.

Read More

NIH: Report on lower dose of mpox vaccine

April 27, 2024

Study highlights need for defined markers of mpox immunity to inform public health use.

Read More

NIH: Lower dose of mpox vaccine is safe and generates six-week antibody response equivalent to standard regimen

Study highlights need for defined markers of mpox immunity to inform public health use.

Read More

Mpox FAQs for Clinicians

April 22, 2024

This fact sheet for clinicians provides information on identifying, controlling, and preventing mpox.

Read More

Mpox Vaccination Basics

This information page from the CDC provides a checklist of factors for those seeking mpox vaccination. Includes a vaccination location finder.

Read More